365 related articles for article (PubMed ID: 12881390)
1. A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer.
Mackay HJ; Hill M; Twelves C; Glasspool R; Price T; Campbell S; Massey A; Macham MA; Uzzel M; Bailey SM; Martin C; Cunningham D
Ann Oncol; 2003 Aug; 14(8):1264-9. PubMed ID: 12881390
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer.
Veronese ML; Stevenson JP; Sun W; Redlinger M; Algazy K; Giantonio B; Hahn S; Vaughn D; Thorn C; Whitehead AS; Haller DG; O'Dwyer PJ
Eur J Cancer; 2004 Mar; 40(4):508-14. PubMed ID: 14962716
[TBL] [Abstract][Full Text] [Related]
3. Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer.
Chayahara N; Tamura T; Yamamori M; Kadowaki Y; Okuno T; Miki I; Tsuda M; Nishisaki H; Maeda T; Inoue Y; Okumura K; Azuma T; Kasuga M; Sakaeda T; Hirai M
Am J Clin Oncol; 2009 Feb; 32(1):56-60. PubMed ID: 19194126
[TBL] [Abstract][Full Text] [Related]
4. Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study.
Sheikh HY; Valle JW; Palmer K; Sjursen A; Craven O; Wilson G; Swindell R; Saunders MP
Br J Cancer; 2007 Jan; 96(1):38-43. PubMed ID: 17213824
[TBL] [Abstract][Full Text] [Related]
5. UFT/leucovorin plus irinotecan in advanced or metastatic colorectal cancer.
Price T; Hill M
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):28-31. PubMed ID: 11098487
[TBL] [Abstract][Full Text] [Related]
6. Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.
Méndez M; Alfonso PG; Pujol E; González E; Castañon C; Cerezuela P; López-Mateos Y; Cruz JJ
Invest New Drugs; 2005 Jun; 23(3):243-51. PubMed ID: 15868381
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer.
Alonso V; Escudero P; Zorrilla M; Isla MD; Herrero A; Mayordomo JI; Martinez-Trufero J; Sáenz A; Tres A; Antón A
Eur J Cancer; 2001 Dec; 37(18):2385-91. PubMed ID: 11720832
[TBL] [Abstract][Full Text] [Related]
8. A feasibility study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG 0304.
Ishida H; Miyake Y; Fukunaga M; Watanabe Y; Kato T; Takemoto H; Furukawa H
Jpn J Clin Oncol; 2009 Sep; 39(9):601-5. PubMed ID: 19535386
[TBL] [Abstract][Full Text] [Related]
9. Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Tanaka A; Ishikawa K; Makuuchi H; Murayama C
Oncology; 2009; 76(5):338-41. PubMed ID: 19307740
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients.
Okabayashi K; Hasegawa H; Ishii Y; Endo T; Ochiai H; Kubota T; Kitagawa Y
Cancer Chemother Pharmacol; 2009 Feb; 63(3):501-7. PubMed ID: 18461329
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.
Comella P; Casaretti R; De Rosa V; Avallone A; Izzo F; Fiore F; Lapenta L; Comella G
Ann Oncol; 2002 Dec; 13(12):1874-81. PubMed ID: 12453855
[TBL] [Abstract][Full Text] [Related]
12. Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer.
Sheikh HY; Valle JW; Waddell T; Palmer K; Wilson G; Sjursen A; Craven O; Swindell R; Saunders MP
Br J Cancer; 2008 Aug; 99(4):577-83. PubMed ID: 18682717
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
Yamaguchi T; Matsumoto H; Yasutome M; Mori T; Takahashi K
Cancer Chemother Pharmacol; 2011 Mar; 67(3):629-35. PubMed ID: 20495917
[TBL] [Abstract][Full Text] [Related]
14. [24 hour infusion of CPT-11/oral UFT/LV].
Iwamoto S; Yoshioka K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):901-3. PubMed ID: 16835476
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II study of irinotecan and UFT for advanced or metastatic colorectal cancer.
Mibu R; Tanaka S; Futami K; Shimada K; Hotokezaka M; Nakahara S; Ichimiya H; Kido H; Hirano Y; Kashiwagi T; Eguchi T; Mitsuki K; Mizumoto K; Tanaka M
Anticancer Res; 2007; 27(4C):2673-7. PubMed ID: 17695431
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer.
Kono T; Ebisawa Y; Tomita I; Chisato N; Kamiya K; Asama T; Ayabe T; Ashida T; Kohgo Y; Kasai S
J Chemother; 2005 Apr; 17(2):224-7. PubMed ID: 15920910
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer.
Schiebe ME; Reese T; Wenz F; Schmidberger H; Engenhart-Cabillic R; Dunst J; Hess CF; Hoffmann W
Anticancer Drugs; 2002 Nov; 13(10):1005-9. PubMed ID: 12439334
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
[TBL] [Abstract][Full Text] [Related]
20. UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.
Petrioli R; Sabatino M; Fiaschi AI; Marsili S; Pozzessere D; Messinese S; Correale P; Civitelli S; Tanzini G; Tani F; De Martino A; Marzocca G; Lorenzi M; Giorgi G; Francini G
Br J Cancer; 2004 Jan; 90(2):306-9. PubMed ID: 14735168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
